Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
293 GBX | -1.01% | +3.53% | +3.53% |
06-10 | Transcript : HUTCHMED Limited Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-10-2024 09:20 AM | |
06-07 | Hutchmed (China) begins trial of menin inhibitor HMPL-506 | AN |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+3.53% | 3.17B | |
+50.70% | 791B | |
+41.96% | 630B | |
-7.15% | 350B | |
+18.77% | 328B | |
+8.79% | 298B | |
+18.02% | 246B | |
+1.27% | 225B | |
+11.95% | 218B | |
+3.68% | 160B |
- Stock Market
- Equities
- HCM Stock
- News HUTCHMED (China) Limited
- Hutchmed (China) to Present Sovleplenib Phase III Data at EHA2024 Congress